
PEAQX
CAS No. 459836-30-7
PEAQX( NVP-AAM077 | NVP-AAM 077 | NVP-AAM-077 )
Catalog No. M17513 CAS No. 459836-30-7
PEAQX(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 58 | In Stock |
![]() ![]() |
5MG | 105 | In Stock |
![]() ![]() |
10MG | 190 | In Stock |
![]() ![]() |
25MG | 342 | In Stock |
![]() ![]() |
50MG | 532 | In Stock |
![]() ![]() |
100MG | 759 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePEAQX
-
NoteResearch use only, not for human use.
-
Brief DescriptionPEAQX(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM).
-
DescriptionPEAQX, also known as NVP-AAM077; is a competitive antagonist at the NMDA receptor. Although originally described as 100-fold selective for GluN1/GluN2A receptors vs. GluN1/GluN2B receptors, more detailed studies of the Ki of PEAQX revealed it only shows a 5 fold difference in affinity for GluN1/GluN2A vs. GluN1/GluN2B receptors. It is also a potent anticonvulsant in animal tests.
-
In Vitro——
-
In Vivo——
-
SynonymsNVP-AAM077 | NVP-AAM 077 | NVP-AAM-077
-
PathwayNeuroscience
-
TargetGamma-secretase
-
RecptorhNMDA 1A/2A receptors
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number459836-30-7
-
Formula Weight516.2
-
Molecular FormulaC17H17BrN3Na2O6P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=c1c(=O)[nH]c2c(c(C(P(=O)(O)O)N[C@H](c3ccc(Br)cc3)C)ccc2)[nH]1
-
Chemical Namesodium ((((S)-1-(4-bromophenyl)ethyl)amino)(2,3-dioxidoquinoxalin-5-yl)methyl)phosphonate hydrate .
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Auberson YP, et al. Bioorg Med Chem Lett. 2002 Apr 8;12(7):1099-102.
molnova catalog



related products
-
Legumain inhibitor 1
Legumain inhibitor 1 is a highly potent and specific Legumain inhibitor with potential anticancer activity for cancer research.
-
Compound W
The compound is an inhibitor of γ-secretase. It also causes a decrease in the released levels of Aβ42 and notch-1 Aβ-like peptide 25 (Nβ25).
-
RBPJ Inhibitor-1
RBPJ Inhibitor-1 (RIN1), a compound that impedes the functional interaction between RBPJ and SHARP, effectively inhibits NOTCH-dependent tumor cell proliferation.